Comparison of the Immunogenicity of Four Infectious Bursal Disease Intermediate Vaccines in Commercial Broiler Flocks in Iran: A Field Trial Study

Infectious bursal disease (IBD) is a highly contagious disease in young chickens worldwide. The major strategy for the prevention and control of IBD virus (IBDV) is vaccination. Therefore, the present study aimed to compare the immunogenicity of four commercially available IBD vaccines on broilers (...

Full description

Bibliographic Details
Main Authors: M. M. Ebrahimi, A. R. Yousefi, Sh. Shahsavadi, M. Zaghari, M. R. Bassami
Format: Article
Language:English
Published: Razi Vaccine and Serum Research Institute 2020-06-01
Series:Archives of Razi Institute
Subjects:
Online Access:https://archrazi.areeo.ac.ir/article_121493_4e7d2b6e3e0bb4267814bb9b0c3e5f71.pdf
_version_ 1811244688269639680
author M. M. Ebrahimi
A. R. Yousefi
Sh. Shahsavadi
M. Zaghari
M. R. Bassami
author_facet M. M. Ebrahimi
A. R. Yousefi
Sh. Shahsavadi
M. Zaghari
M. R. Bassami
author_sort M. M. Ebrahimi
collection DOAJ
description Infectious bursal disease (IBD) is a highly contagious disease in young chickens worldwide. The major strategy for the prevention and control of IBD virus (IBDV) is vaccination. Therefore, the present study aimed to compare the immunogenicity of four commercially available IBD vaccines on broilers (Ross 308) that were raised in areas with very virulent IBDV infection history. Two commercial broiler farms with four standard poultry houses were selected in Alborz (n=6,250 birds per house) and Khorasan Razavi (n=8,000 birds per house) provinces of Iran. In each farm, the houses were randomly assigned to one of the four IBD intermediate vaccine brands including Dn, Vc, Ch, and Razi. The birds in Alborz were vaccinated against IBDV via drinking water at 18 and 22; and 15 and 21 days of age in Alborz and Khorasan Razavi flocks, respectively. The enzyme-linked immunosorbent assay antibody titers against IBDV were measured in 20 birds per group at 1, 28, 35, and 42 days of age. In addition, production attributes including body weight, feed conversion ratio, mortality, and production index were measured during the research period. According to the findings, the IBD antibody titers were not affected by the vaccine brands at 28, 35, and 42 days of age (P>0.05). Following the second IBD vaccination, an increasing trend in IBD antibody titers was noted in the Razi vaccine as well as other brands at days 35 and 42 compared to the previously recorded titers (P<0.05). Moreover, the production attributes of the flocks receiving various IBDV vaccine brands were not different (P>0.05). Regarding the productivity indices and high immunogenicity levels, the results indicated that the potential of the IBD Razi vaccine was comparable to the other investigated brands of commercial IBD vaccines, and nominated it as an immunogenic candidate vaccine for use in commercial broilers.
first_indexed 2024-04-12T14:29:38Z
format Article
id doaj.art-2ec95e3dd83d466caee7c01710e2bded
institution Directory Open Access Journal
issn 0365-3439
2008-9872
language English
last_indexed 2024-04-12T14:29:38Z
publishDate 2020-06-01
publisher Razi Vaccine and Serum Research Institute
record_format Article
series Archives of Razi Institute
spelling doaj.art-2ec95e3dd83d466caee7c01710e2bded2022-12-22T03:29:19ZengRazi Vaccine and Serum Research InstituteArchives of Razi Institute0365-34392008-98722020-06-0175220521210.22092/ari.2019.124890.1292121493Comparison of the Immunogenicity of Four Infectious Bursal Disease Intermediate Vaccines in Commercial Broiler Flocks in Iran: A Field Trial StudyM. M. Ebrahimi0A. R. Yousefi1Sh. Shahsavadi2M. Zaghari3M. R. Bassami4Department of Poultry Viral Vaccines Research and Production, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, IranDepartment of Pathology and Experimental Animals, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, IranDepartment of Poultry Viral Vaccines Research and Production, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, IranDepartment of Animal Sciences, College of Agriculture and Natural Resource, University of Tehran, Karaj, IranDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, IranInfectious bursal disease (IBD) is a highly contagious disease in young chickens worldwide. The major strategy for the prevention and control of IBD virus (IBDV) is vaccination. Therefore, the present study aimed to compare the immunogenicity of four commercially available IBD vaccines on broilers (Ross 308) that were raised in areas with very virulent IBDV infection history. Two commercial broiler farms with four standard poultry houses were selected in Alborz (n=6,250 birds per house) and Khorasan Razavi (n=8,000 birds per house) provinces of Iran. In each farm, the houses were randomly assigned to one of the four IBD intermediate vaccine brands including Dn, Vc, Ch, and Razi. The birds in Alborz were vaccinated against IBDV via drinking water at 18 and 22; and 15 and 21 days of age in Alborz and Khorasan Razavi flocks, respectively. The enzyme-linked immunosorbent assay antibody titers against IBDV were measured in 20 birds per group at 1, 28, 35, and 42 days of age. In addition, production attributes including body weight, feed conversion ratio, mortality, and production index were measured during the research period. According to the findings, the IBD antibody titers were not affected by the vaccine brands at 28, 35, and 42 days of age (P>0.05). Following the second IBD vaccination, an increasing trend in IBD antibody titers was noted in the Razi vaccine as well as other brands at days 35 and 42 compared to the previously recorded titers (P<0.05). Moreover, the production attributes of the flocks receiving various IBDV vaccine brands were not different (P>0.05). Regarding the productivity indices and high immunogenicity levels, the results indicated that the potential of the IBD Razi vaccine was comparable to the other investigated brands of commercial IBD vaccines, and nominated it as an immunogenic candidate vaccine for use in commercial broilers.https://archrazi.areeo.ac.ir/article_121493_4e7d2b6e3e0bb4267814bb9b0c3e5f71.pdfantibody titerbroilerimmunityinfectious bursal diseasevaccination
spellingShingle M. M. Ebrahimi
A. R. Yousefi
Sh. Shahsavadi
M. Zaghari
M. R. Bassami
Comparison of the Immunogenicity of Four Infectious Bursal Disease Intermediate Vaccines in Commercial Broiler Flocks in Iran: A Field Trial Study
Archives of Razi Institute
antibody titer
broiler
immunity
infectious bursal disease
vaccination
title Comparison of the Immunogenicity of Four Infectious Bursal Disease Intermediate Vaccines in Commercial Broiler Flocks in Iran: A Field Trial Study
title_full Comparison of the Immunogenicity of Four Infectious Bursal Disease Intermediate Vaccines in Commercial Broiler Flocks in Iran: A Field Trial Study
title_fullStr Comparison of the Immunogenicity of Four Infectious Bursal Disease Intermediate Vaccines in Commercial Broiler Flocks in Iran: A Field Trial Study
title_full_unstemmed Comparison of the Immunogenicity of Four Infectious Bursal Disease Intermediate Vaccines in Commercial Broiler Flocks in Iran: A Field Trial Study
title_short Comparison of the Immunogenicity of Four Infectious Bursal Disease Intermediate Vaccines in Commercial Broiler Flocks in Iran: A Field Trial Study
title_sort comparison of the immunogenicity of four infectious bursal disease intermediate vaccines in commercial broiler flocks in iran a field trial study
topic antibody titer
broiler
immunity
infectious bursal disease
vaccination
url https://archrazi.areeo.ac.ir/article_121493_4e7d2b6e3e0bb4267814bb9b0c3e5f71.pdf
work_keys_str_mv AT mmebrahimi comparisonoftheimmunogenicityoffourinfectiousbursaldiseaseintermediatevaccinesincommercialbroilerflocksiniranafieldtrialstudy
AT aryousefi comparisonoftheimmunogenicityoffourinfectiousbursaldiseaseintermediatevaccinesincommercialbroilerflocksiniranafieldtrialstudy
AT shshahsavadi comparisonoftheimmunogenicityoffourinfectiousbursaldiseaseintermediatevaccinesincommercialbroilerflocksiniranafieldtrialstudy
AT mzaghari comparisonoftheimmunogenicityoffourinfectiousbursaldiseaseintermediatevaccinesincommercialbroilerflocksiniranafieldtrialstudy
AT mrbassami comparisonoftheimmunogenicityoffourinfectiousbursaldiseaseintermediatevaccinesincommercialbroilerflocksiniranafieldtrialstudy